Kim Milliken is an experienced professional in the field of regulatory affairs and quality control with a strong background in microbiology. With a degree in Microbiology from the University of New Hampshire, Kim has held various roles at companies such as Verve Therapeutics, Takeda, Lonza Biologics, and Biogen. Kim's expertise ranges from QC Analyst to Executive Director Regulatory CMC, showcasing a well-rounded career in the pharmaceutical industry.